Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Losartan for inflammation and immune recovery in HIV
NCT02049307Phase 2Completed
- Sponsor
- Hennepin Healthcare Research Institute
- Start
- Oct 2014
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of losartan in human immunodeficiency virus infection (HIV), sponsored by Hennepin Healthcare Research Institute. Started Oct 2014; status: completed.
02
Drugs
losartan
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT02049307.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02049307.